NCT05243082View on ClinicalTrials.gov

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 14, 2022

Primary Completion Date

January 14, 2025

Study Completion Date

November 11, 2029

Conditions
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
Interventions
DEVICE

Radio frequency ablation

Radio frequency ablation of pancreatic neuroendocrine tumors

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

lead

Oslo University Hospital

OTHER